Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 494

1.

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.

Liver Transpl. 2009 Dec;15(12):1872-81. doi: 10.1002/lt.21954.

2.

The natural history of hepatitis C cirrhosis after liver transplantation.

Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.

Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784.

3.

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.

Liver Transpl. 2006 Apr;12(4):560-5.

4.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.

Liver Transpl. 2009 Jun;15(6):619-28. doi: 10.1002/lt.21761.

5.

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.

Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.

Liver Transpl. 2009 Dec;15(12):1783-91. doi: 10.1002/lt.21907.

6.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

7.

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.

Liver Transpl. 2007 May;13(5):687-92.

8.

Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.

Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.

Transplantation. 2007 Aug 15;84(3):331-9.

PMID:
17700157
9.

Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.

Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.

Transplantation. 2006 Feb 15;81(3):350-4.

PMID:
16477219
10.

Is recurrent hepatitis C worse with living donors?

Kuo A, Terrault NA.

Curr Opin Organ Transplant. 2009 Jun;14(3):240-4. doi: 10.1097/MOT.0b013e32832b1f1d. Review.

PMID:
19395968
11.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

12.

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.

Hepatology. 1999 Jan;29(1):250-6.

PMID:
9862874
13.

Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.

Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW Jr, Langnas AN.

Liver Int. 2007 Aug;27(6):758-63.

PMID:
17617118
14.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

15.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061
16.

Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.

Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD.

Liver Transpl. 2005 Dec;11(12):1567-73.

17.

The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.

Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.

Liver Transpl. 2008 Dec;14(12):1778-86. doi: 10.1002/lt.21598.

18.

Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.

Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.

Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.

PMID:
19376421
19.

Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.

McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.

Liver Transpl. 2004 Aug;10(8):975-85.

20.

One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.

Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.

Liver Transpl. 2004 Oct;10(10):1240-7.

Supplemental Content

Support Center